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The effect of tricyclic antidepressants (TCA) on phospholipid bilayer structure and dynamics was studied
to provide insight into the mechanism of TCA-induced intracellular accumulation of lipids (known
as lipidosis). Specifically we asked if the lipid–TCA interaction was TCA or lipid specific and if
such physical interactions could contribute to lipidosis. These interactions were probed in multilamellar
vesicles and mechanically oriented bilayers of mixed phosphatidylcholine–phosphatidylglycerol (PC–PG)
phospholipids using 31P and 14N solid-state NMR techniques. Changes in bilayer architecture in the
presence of TCAs were observed to be dependent on the TCA’s effective charge and steric constraints. The
results further show that desipramine and imipramine evoke distinguishable changes on the membrane
surface, particularly on the headgroup order, conformation and dynamics of phospholipids. Desipramine
increases the disorder of the choline site at the phosphatidylcholine headgroup while leaving the
conformation and dynamics of the phosphate region largely unchanged. Incorporation of imipramine
changes both lipid headgroup conformation and dynamics. Our results suggest that a correlation between
TCA-induced changes in bilayer architecture and the ability of these compounds to induce lipidosis
is, however, not straightforward as imipramine was shown to induce more dramatic changes in bilayer
conformation and dynamics than desipramine. The use of 14N as a probe was instrumental in arriving at
the presented conclusions. Copyright  2004 John Wiley & Sons, Ltd.
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INTRODUCTION
The class of tricyclic antidepressants, which includes
imipramine and its metabolized product desipramine
(Fig. 1), is known to interact strongly with the lipid bilayer.1 – 5
The ‘amine hypothesis’ suggests that the pharmacological
effect of these drugs is to block the re-uptake of neuro-
transmitters at the nerve synapses.6 It is also known that
the incorporation of these compounds into lipid bilayers
leads to intracellular accumulation of various phospholipids,
a process known as lipidosis.7 – 12 Tricyclic antidepressant
(TCA)-induced lipidosis has been linked to the ability of these
compounds to inhibit phospholipases which are responsible
for phospholipid degradation.6,13,14 However, the mecha-
nistic connection between TCA–lipid interaction and phos-
pholipidosis remains puzzling. It is unclear whether a TCA
interacts directly with the phospholipids and consequently
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renders the lipid unsuitable for degradation, or with the
phospholipase thereby inactivating the enzyme.11 Since the
process of sequestering peripheral membrane and cytosolic
proteins to the membrane has been observed to be initially
driven by an electrostatic interaction between the lipid head-
groups and protein,15 – 18 it is plausible that the introduction
of the charged TCA drug changes the electrostatic profile of
the lipid bilayer and therefore may contribute to inhibit the
phospholipase–membrane contact. In this conceptual frame,
it is important to ask how the lipid bilayer structure and
dynamics change at the atomic level upon the introduction
of positively charged amphiphiles. Specifically, it would be
valuable to test if there is a correlation between the different
observed physiological effects of TCA homologues, such as
desipramine and imipramine, and spectroscopically observ-
able changes in the electrostatic profile of the membrane
surface.
The introduction of any type of inclusion, here defined
as any non-lipid molecule, into a lipid bilayer rearranges
the number and type of interactions that stabilize the bilayer
structure. Probing these types of interactions in a quanti-
tative manner has proven difficult through spectroscopic
methods. The work of Pasenkiewicz-Gierula and co-workers
using molecular simulations of lipid bilayers to investigate
Copyright  2004 John Wiley & Sons, Ltd.























Figure 1. Structures of TCA drugs: (A) iminodibenzyl;
(B) desipramine; (C) imipramine.
these types of forces has recently produced a wealth of
information.19,20 These studies showed that there are two
types of short-distance interactions that are predicted to
occur between phosphatidylcholine (PC) headgroups. These
interactions are water-mediated hydrogen bonds and charge
association (charge pairs), each of which can be inter- or
intramolecular.19,21,22 Such interactions are responsible for
the formation of an extended network among PC head-
groups linking 98% PC in a membrane.19 The sites of these
interactions are the positively charged nitrogen atom in the
choline headgroup, the negatively charged non-ester phos-
phate oxygens (see O13 in Fig. 2) and the carbonyl oxygens
(see O22 and O32 in Fig. 2).
Solid-state NMR techniques on naturally abundant NMR-
active nuclei of 31P and 14N (100.0 and 99.63%, respectively)
are ideal to study these changes in the environment near
the lipid headgroup in model lipid bilayers. Nitrogen-14 is
a quadrupole nucleus that shares deuterium’s sensitivity to
changes in bilayer surface charge (the ‘molecular voltmeter
effect’).23 In spite of its high natural abundance and sensitiv-
ity to changes in electric field gradient, relatively few studies
have made use of this nucleus.1,24 – 32 From the results of these
studies, three important conclusions of particular relevance
to this investigation can be drawn. First, the 14N nucleus
appears to be more sensitive than deuterium since slight dis-
tortions of the tetrahedral symmetry upon addition of anionic
amphiphiles result in large spectral changes.32 Second, the
order of the choline headgroup is independent of the order
of the acyl chains and the phosphate moiety, as shown by
the observed concurrent 28% decrease in the 14N quadrupole
splitting and 20% increase in 31P chemical shift anisotropy
(CSA) span upon addition of the local anesthetic tetracaine
(at a lipid to tetracaine molar ratio of 2.6 : 1).30 Finally, the
choline headgroup is sensitive to desipramine, as evidenced
by the 50% decrease in the lipid quadrupole splitting in the
presence of the drug in a 1 : 2 mole ratio.1 Nitrogen-14 has an
additional advantage in studying model lipid bilayers as it
allows for the isolated study of PC since most other 14N nuclei
(from proteins, other lipids or drugs) do not contribute to the
14N NMR signal due to large quadrupole coupling constants.
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Figure 2. Structures of (A) 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphatidylcholine (POPC) and (B) 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphatidylglycerol (POPG). The phospholipid
atom numbering scheme is identical with that used by
Pasenkiewicz-Gierula et al.19
In this study, the interaction of TCAs with mechani-
cally oriented lipid bilayers and multilamellar lipid vesicles
composed of a mixture of zwitterionic (PC) and anionic
(phosphatidylglycerol) lipids was monitored by solid-state
NMR techniques using as probes the 31P and 14N NMR
active nuclei located at the lipid headgroups. In general, it
is shown that 14N NMR may be coupled to 31P NMR tech-
niques to distinguish between changes in lipid headgroup
conformation and dynamics upon the inclusion of different
charged amphiphiles. Specifically, the results show that the
inclusion of desipramine in lipid bilayers results primarily
in a decrease in order of the PC lipid headgroup while leav-
ing the conformation of the headgroup largely unchanged.
In contrast, imipramine is shown to alter both conformation
and order of the lipid headgroups. Changes in overall bilayer
architecture were determined to be highly dependent on the
TCA’s effective charge and steric constraints. It is concluded
that the ability of TCAs to induce lipidosis in vivo is not
correlated in a straightforward manner with TCA-induced




phatidylcholine (POPC) and 1-palmitoyl-2-oleoyl-sn-gly-
cero-3-phosphatidylglycerol (POPG) were purchased from
Avanti Polar Lipids (Alabaster, AL, USA) and used without
further purification. The purity of the lipids was checked
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by thin-layer chromatography using CH3Cl–CH3OH–H2O
(85 : 30 : 3) as solvent system and iodine as visualiza-
tion agent. Imipramine hydrochloride and desipramine
hydrochloride were purchased from Sigma Chemical (St.
Louis, MO, USA) and iminodibenzyl from Aldrich Chemical
(Milwaukee, WI, USA). All chemicals were used without
further purification.
Sample preparation
Oriented lipid bilayers were prepared by one of two
methods, in which the only difference was the use of
naphthalene, as described previously.33 Briefly, the drug
compound was first dissolved in a chloroform solution
containing the lipid of interest. The mixture was dried
under a nitrogen flow and the residue was dissolved in
2 : 1 chloroform–methanol containing a 1 : 1 molar ratio
of naphthalene, briefly sonicated and then spread on
the surface of 2–6 thin 0.05 ð 11 ð 21 mm glass plates
(Paul Marienfeld, Bad Mergentheim, Germany) that had
previously been cleaned with chloroform. Plates were
allowed to air-dry and residual traces of the organic solvents
were removed at room temperature under high vacuum
for at least 8 h. Each plate contained ¾2 mg of lipid. The
removal of naphthalene was confirmed by 1H solution NMR
after dissolving the drug–lipid film in CDCl3. Samples were
subsequently indirectly hydrated in a hydration chamber of
93% relative humidity using saturated NH4H2PO4 solution34
at 37 °C for 2 days. After 2 days, a minimum of 28 mol
of 4 °C water per mole of lipid was added to the sides
of the plates so as to achieve complete hydration.35,36 The
plates were stacked, wrapped with Parafilm, sealed in plastic
bags (Plastic Bagmart, Marietta, GA, USA) and further
equilibrated at 4 °C for several hours to 2 days. Complete
hydration was monitored visually by the absence of a
residual powder pattern.
Experiments were performed with the bilayer normal of
the oriented sample parallel to the external magnetic field of
the spectrometer. Multilamellar vesicle (MLV) samples were
prepared by adding 100 wt% water (¾42 mol of water per
mole of lipid) to the dried lipid or lipid–drug mixture (5 mg
for 31P powder spectra and 20–60 mg of lipid for 14N), then
homogenized using several liquid nitrogen freeze–room
temperature thaw cycles. During the sample preparation,
special care is needed with imipramine owing to its light
sensitivity.
NMR spectroscopy
All experiments were performed on a Chemagnetics/Varian
Infinity solid-state NMR spectrometer operating at resonance
frequencies of 400.14, 161.979 and 28.9 MHz for 1H, 31P and
14N nuclei, respectively. Experiments on oriented lipid bilay-
ers were performed using laboratory-built double resonance
(1H/14N and 1H/31P) probes fitted with a five-turn rectan-
gular coil made of a flat wire (2 mm wide) with a spacing
of 1 mm between turns. Experiments on MLV samples were
performed using a commercial Varian/Chemagnetics double
resonance probe. All experiments were conducted at 35 °C
unless noted otherwise. 31P spectra were acquired with a
chemical shift echo pulse sequence 90° – –180° under pro-
ton decoupling with a recycle delay of 3 s. Typical values for
the 90° pulse width and  delay were 3–4 and 80 µs, respec-
tively. A quadrupole echo pulse sequence 90° – –90° was
used to acquire the 14N magnetization under proton decou-
pling with a recycle delay of 3 s. Typically, the values of the
90° pulse width and  were 3–5 and 80 µs, respectively. 1H
decoupling r.f. field strengths of 35 and 65 kHz were used
during the signal acquisition in the 31P and 14N experiments,
respectively. Neither increasing the decoupling r.f. power
nor implementing a TPPM decoupling sequence37 in the 1H
r.f. channel increased the resolution of the 14N spectral lines.
For 31P and 14N NMR experiments, 85% phosphoric acid and
ammonium chloride solution were used as a standard ref-
erence samples (0 ppm). On average, 12000 transients were
collected for 14N spectra whereas <1000 transients were
required for the 31P spectra. All of the spectra were obtained
from a complex FID and data sets were zero-filled to 4096
points and processed with a maximum line broadening of
200 Hz. The program IGOR Pro Version 3.1 for Windows
(Wavemetrics, Lake Owesgo, OR, USA) was used to simulate
powder spectra.
RESULTS
Solid-state NMR experiments were performed to obtain 14N
and 31P spectra of mixed POPC–POPG MLVs and oriented
bilayers. This binary lipid system was selected for the
following reasons: (1) POPC is a representative of lipids in the
plasma membrane of eukaryotic cells and POPG is a suitable
substitute for phosphatidylserine, the most abundant acidic
lipid in mammalian cells,38 (2) in combination with POPG,
POPC has been widely used in oriented bilayer studies of
membrane-associated peptides16,39,40 and (3) both POPC and
POPG are in the liquid crystalline phase at a physiological
temperature [the temperature, TC, for the gel Lˇ to liquid
crystalline L˛ phase transition is 2.5 š 2.4 °C for POPC
and 0 š 1 °C for POPG] and are assumed to be a good model
for cellular membranes.41,42
Figure 3 shows 31P spectra obtained at 35 °C of MLVs
and mechanically oriented bilayers of POPC, POPG and
POPC–POPG mixtures with different molar ratios. Except for
the spectrum of 4 : 1 POPC–POPG, all of the powder spectra
can be fitted by a single powder pattern with the character-
istic lineshape of the lipids in the liquid crystalline phase.
Computer simulations were used to calculate CSA spans of
47.0 š 1.0 ppm for pure POPC, 44.0 š 1.0 ppm for the larger
powder pattern in 4 : 1 POPC–POPG, 41.0 š 2.0 ppm for
1 : 1 POPC–POPG, 38.5 š 1.0 ppm for 1 : 4 POPC–POPG and
37.0 š 1.0 ppm for pure POPG. The CSA spans for the pure
lipids are in good agreement with previously reported values
for phosphatidylcholines and phosphatidylglycerols.16,36,39
Given that the 31P CSA spans of POPC and POPG powder
spectra are markedly different (the span of the POPC spec-
trum is 10 ppm larger than that of the POPG spectrum), a
single CSA span observed in the 31P spectra of the lipid mix-
tures indicates that the presence of POPC evokes a change
in the headgroup conformation of POPG and vice versa.
In contrast, the 31P powder spectrum of 4 : 1 POPC–POPG
shows two distinct CSA spans with clear resolution on the
Copyright  2004 John Wiley & Sons, Ltd. Magn. Reson. Chem. 2004; 42: 105–114













31P Chemical Shift (ppm)
Figure 3. 31P chemical shift spectra of POPC–POPG lipid
MLV (A–E) and mechanically oriented (F–K) samples. The
POPC : POPG molar ratios are given on the traces.
perpendicular (higher field) edge of the powder spectrum.
Considering the 4 : 1 POPC–POPG molar ratio used, the peak
intensities of the two perpendicular edges are in discrepancy,
with the edge at the lower field side being significantly more
intense than expected if each CSA span was to be assigned
exclusively to POPC and POPG. As shown in Fig. 3, this dis-
crepancy was also observed in the oriented bilayer spectra
where, for example, the area ratios of the two peaks in the 4 : 1
PC–PG and 3 : 1 PC–PG spectra were calculated to be 2.6 : 1
and 2.4 : 1, respectively. For the 1 : 1 POPC–POPG mixture, a
narrow single line with chemical shift value close to that mea-
sured for the pure POPG spectrum is observed, confirming
that (1) the POPC headgroup conformation is affected by the
presence of neighboring negatively charged POPG molecules
and (2) both lipids were homogenously mixed. In the spec-
trum of the 2 : 1 POPC–POPG mixture, two lines appear to be
merged in to one, as evidenced by the relatively broad line,
suggesting that POPC and POPG are miscible but in the inter-
mediate dynamics range. 31P spectra of POPC–POPG lipid
bilayers oriented with bilayer normal parallel to B0 showed
two peaks at the parallel edge (corresponding to two dis-
tinct lipid populations and two // tensor components) for
POPC : POPG lipid molar ratios >2 : 1. The lipid populations
giving rise to these lines are assigned to POPC- and POPG-
enriched domains and not to pure POPC and pure POPG
domains since the ratio of the line intensities differs markedly
from the stoichiometric ratio of lipids used in each sample
(e.g. for 4 : 1 PC–PG the peak area ratio was 2.6 : 1). Hence it
follows that the powder spectrum with a larger CSA span cor-
responds to a lipid population composed of POPC-enriched
domains and the spectrum with a smaller CSA span corre-
sponds to a lipid population of POPG-enriched domains.
To investigate the composition of each lipid domain and
the relative affinities of each TCA for POPC and POPG,
the 31P powder spectra of POPC and POPG MLVs with
25 mol% desipramine and imipramine incorporated were
recorded (Fig. 4). Each spectrum exhibits a single powder
pattern with lineshape characteristic of lipids in the L˛
fluid lamellar phase. The CSA spans were determined by
computer simulation to be 49.0 š 1.0, 57.0 š 1.0, 38.0 š 1.0
and 44.0 š 1.0 ppm for POPC–desipramine [Fig. 4(A)],
POPC–imipramine [Fig. 4(B)], POPG–desipramine
[Fig. 4(C)] and POPG–imipramine [Fig. 4(D)], respectively.
By comparing the CSA spans of the 31P spectra of POPC
and POPG in the absence of any drugs (Fig. 3) with those
in the presence of drugs (Fig. 4), it is possible to conclude
that the incorporation of either desipramine or imipramine
changes the lipid headgroup conformation/dynamics result-
ing in an increase in the CSA span of POPC and POPG (see
Table 1). Importantly, the increases in the CSA spans for
both lipids are much more dramatic upon incorporation of
imipramine than desipramine as, for example, the CSA span
of POPC MLVs increases from 47.0 š 1.0 ppm without drug
to 49.0 š 1.0 ppm with desipramine and to 57.0 š 1.0 ppm
with imipramine. No change was observed in the spectrum
of POPC and POPG MLVs with iminodibenzyl incorporated
(spectra not shown).
Figure 5 shows the powder and oriented 31P chemical
shift spectra of 4 : 1 POPC–POPG mixtures with drugs
incorporated. As was previously seen in the spectrum
of 4 : 1 POPC–POPG MLVs, all of the powder spec-
tra of 4 : 1 POPC–POPG MLVs with 25% molar drugs
are composed of two powder patterns with two resolv-
able perpendicular edges. As expected, the spectra of the
oriented bilayers of analogous lipid and drug compo-
sition also show two well-resolved parallel edges. The
CSA spans for the individual powder patterns in the
31P powder spectrum of 4 : 1 POPC–POPG with 25 mol%
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Figure 4. 31P chemical shift powder spectra of POPC or POPG
with 25 mol% drug incorporated. (A) POPC–desipramine;
(B) POPC–imipramine; (C) POPG–desipramine;
(D) POPG–imipramine. Dashed lines are to guide the eye.
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Table 1. 14N quadrupole splittings and 31P chemical shift anisotropy spans for MLV samples






None PC 47.0 š 1.0 10.8 š 0.2 3
PC–PG (4 : 1) 44.0 š 1.0a 11.5 š 0.2 3, 6(A)
PC–PG (1 : 1) 41.0 š 1.0 n.r. 3
PC–PG (1 : 4) 38.5 š 1.0 n.r. 3
PG 37.0 š 1.0 n.a. 3
25% Desipramine PC–PG (4 : 1) 42.0 š 1.0 7.5 š 0.2 5(A), 6(B)
39.0 š 1.0
PC 49.0 š 1.0 n.r. 4(A)
PG 38.0 š 1.0 n.a. 4(C)
25% Imipramine PC–PG (4 : 1) 57.0 š 1.0 8.5 š 0.2 5(B), 6(C)
43.7 š 1.0
PC 57.0 š 1.0 n.r. 4(B)
PG 44.0 š 1.0 n.a. 4(D)
25% Iminodibenzyl PC–PG (4 : 1) 48.0 š 2.0 11.4 š 0.2 5(C), 6(D)
a Only the largest CSA span could be measured.
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Figure 5. 31P chemical shift spectra of 4 : 1 POPC–POPG
MLV (left) and mechanically oriented (right) samples at various
molar concentrations of a drug: (A) and (D) 25 mol%
desipramine; (B) and (E) 25 mol% imipramine; (C) and (F)
25 mol% iminodibenzyl.
42.0 š 1.0 and 39.0 š 1.0 ppm. In comparison, the pow-
der spectrum of the same lipid mixtures with 25 mol%
imipramine [Fig. 5(B)] was deconvoluted into two powders
with increased CSA spans relative to those calculated for
desipramine, specifically 57.0 š 1.0 and 43.7 š 1.0 ppm. Fur-
thermore, the CSA span of the powder spectra of POPC
MLVs with desipramine incorporated is significantly larger
than the corresponding larger CSA span observed in the
spectra of the binary lipid mixture with desipramine incor-
porated (42.0 š 1.0 versus 49.0 š 1.0 ppm). In contrast, the
spans of the POPC powder spectra in both the binary and
ternary lipid–imipramine mixtures are equal within error
57 š 1.0 ppm.
At the very least, these results indicated that desipramine
and imipramine interact with the lipids in a distinguishable
manner and that in the desipramine case the effect of
the drug on the overall bilayer architecture results from
a combination of three pairwise interactions (PC–drug,
PG–drug and PC–PG) that are not independent. A more
detailed analysis of this observation is given in the Discussion
section. The incorporation of iminodibenzyl results in only
a slight broadening of the spectral lines without changing
the 31P CSA span 48.0 š 2.0 ppm. In summary, all of the
spectra confirmed the above-outlined trends for pure lipid
systems. Briefly, (1) all of the spectra of 4 : 1 POPC–POPG
mixture exhibit two peaks at the parallel edge in oriented
spectra and two peaks at the perpendicular edge in powder
spectra; (2) changes in the value of // in the powder
spectrum (the edge at lower field) and the chemical shift
values of the peak at the lower field in oriented spectra
for bilayers without drug and with 25 mol% desipramine
or iminodibenzyl are small; (3) the // tensor components
for both lipid bilayer populations with 25 mol% imipramine
incorporated are significantly larger and the corresponding
peaks are broader than those observed from all other
spectra; (4) all of the spectra of oriented bilayers with and
without drug exhibit peak intensity ratios markedly different
from the stochiometric ratio of 4 : 1 PC : PG. Specifically,
the peak area ratios for 4 : 1 POPC–POPG bilayers with
25 mol% desipramine [Fig. 5(D)], imipramine [Fig. 5(E)] and
iminodibenzyl [Fig. 5(F)] were calculated to be 1.9 : 1, 1.8 : 1
and 2.8 : 1, respectively, supporting the contention that the
lipid populations giving rise to each peak are not due to
separate POPC and POPG populations but to the existence
of two distinct lipid domains.
Together, the results presented thus far of 31P chemical
shift spectra of mixed and individual lipids with drugs
allow us to draw a number of important conclusions.
First, it is verified that both desipramine and imipramine
Copyright  2004 John Wiley & Sons, Ltd. Magn. Reson. Chem. 2004; 42: 105–114
110 J. S. Santos, D.-K. Lee and A. Ramamoorthy
are most likely positively charged at neutral pH, as
expected based on the reported pKa values of 9.5 and
10.2 for these compounds.43 This conclusion is drawn from
previous studies where an increase in the 31P CSA span
for phosphatidylcholines was interpreted in terms of a
reorientation of the P–N dipole vector towards the water
layer caused by a repulsion between a cationic amphiphile
and the lipid choline site.32 Second, 25 mol% desipramine
and imipramine are fully miscible in both lipids as a
single CSA pattern describes the powder spectra. Third,
by comparison with the 31P powder spectra of 25 mol%
desipramine and imipramine in 4 : 1 POPC–POPG [Fig. 5(A)
and (B), respectively], it is possible to assign the outer
powder pattern (the one with larger CSA span) to a lipid
domain enriched in POPC and the inner powder pattern to
a lipid domain enriched in POPG in both cases. Finally, a
comparison of CSA spans of 31P powder spectra of POPC,
4 : 1 POPC–POPG and POPC with 25 mol% desipramine
incorporated shows that desipramine and POPG change
the 31P CSA span of POPC in opposite directions. Notably,
the increase in the 31P CSA span of POPC is even more
pronounced upon introduction of imipramine.
To investigate further the effect of POPG and drugs on the
POPC conformation and dynamics in a more specific manner,
the 14N powder spectra of 4 : 1 POPC–POPG without
drug and with 25 mol% desipramine, imipramine and
iminodibenzyl incorporated were recorded [Fig. 6(A)–(D)].
The 14N powder spectra POPC (spectrum not shown) and
4 : 1 POPC–POPG [Fig. 6(A)] MLVs in the L˛ phase showed
significantly narrower quadrupolar splittings than those
predicted for an immobile POPC (a quadrupole splitting
-20 -15 -10 -5 0 5 10 15 20





Figure 6. 14N quadrupole coupling powder spectra of 4 : 1
POPC–POPG at various molar concentrations of a drug:
(A) without drug; (B) 25 mol% desipramine; (C) 25 mol%
imipramine; (D) 25 mol% iminodibenzyl. Dashed lines are to
guide the eye.
of 101.25 kHz). The separations between the peak maxima
Q of POPC (spectrum not shown) and 4 : 1 POPC–POPG
[Fig. 6(A)] are 10.8 š 0.2 and 11.5 š 0.2 kHz, respectively,
in agreement with previous studies.24,31 This averaging of
the quadrupole interaction is achieved by the axial rotation
of the lipid molecules at a rate faster than the effective
static quadrupole coupling constant for the 14N nucleus
in the choline headgroup. The addition of desipramine
[Fig. 6(B)] and imipramine [Fig. 6(C)] to 4 : 1 POPC–POPG
at a 25 mol% concentration resulted in noticeable changes
in the quadrupole splitting (Q D 7.5 š 0.2 and 8.5 š
0.2 kHz, respectively). In contrast, incorporation of the same
concentration of iminodibenzyl in 4 : 1 POPC–POPG MLVs
[Fig. 6(D)] revealed no change in the quadrupole splitting
of the choline group. A decrease in the quadrupole splitting
is interpreted as a decrease in the order parameter for the
nitrogen nucleus at the POPC choline site. As such, we
conclude that the inclusion of desipramine and imipramine at
25 mol% into 4 : 1 POPC–POPG mixture decreases the order
parameter of the choline headgroup, whereas the addition of
iminodibenzyl at the same molar concentration broadens the
lines without changing, to a first approximation, the order
parameter. Incorporation of desipramine results in a larger
decrease in the order parameter at the choline headgroup
than imipramine. Finally, given that approximately the
same weight of lipid was present in all samples and the
number of scans was approximately the same for all 14N
spectra obtained, we interpret the visible increase in the
line broadening upon the inclusion of drugs as a noticeable
change in the 14N relaxation time.
To test if the effect of desipramine on the 14N order
parameter of the choline group of POPC was concentra-
tion dependent, the 14N spectra of mechanically oriented
4 : 1 POPC–POPG bilayers in the presence of different
desipramine concentrations were recorded (Fig. 7). The
quadrupole splittings oriented observed from the oriented
spectra were 23.0 š 0.2, 16.2 š 0.2, 13.6 š 0.4, 11.6 š 0.4 and
10.2 š 0.6 kHz for 4 : 1 POPC–POPG with desipramine con-
centrations of 3, 20, 30, 40 and 50 mol%, respectively.
The ratio of oriented to Q is related to an angle, ˛,
defined by the following expression:
oriented
Q
D j3 cos2 ˛  1j 1
where ˛ is the angle between the primary quadrupole inter-
action averaging axis and the bilayer normal (parallel to
B0). Because this averaging axis has been shown previ-
ously to be approximately collinear with the lipid symmetry
axis, it is possible to estimate the orientation of POPC with
respect to the bilayer normal at different desipramine con-
centrations. Since oriented for 4 : 1 POPC–POPG bilayers
with 25 mol% desipramine incorporated was not directly
measured, this value is calculated to be 14.9 š 0.3 kHz by
averaging the oriented values obtained from 20 and 30 mol%
desipramine incorporated. Substitution of this value and
of the Q value observed in the 14N powder spectra of
4 : 1 POPC–POPG with 25 mol% desipramine (7.5 kHz) into
Eqn (1) yields ˛ D 0, indicating that the incorporation of
25 mol% desipramine into 4 : 1 POPC–POPG bilayers leaves
Copyright  2004 John Wiley & Sons, Ltd. Magn. Reson. Chem. 2004; 42: 105–114
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Figure 7. 14N quadrupole coupling spectra of mechanically
oriented 4 : 1 POPC–POPG at various molar concentrations of
desipramine: (A) 3; (B) 20; (C) 30; (D) 40; (E) 50 mol%.
POPC with its symmetry axis oriented parallel to the bilayer
normal. This leads us to conclude that desipramine imparts
a disorder on the POPC headgroup while leaving the lipid
orientation unchanged. This conclusion is consistent with the
data collected by Rothgeb and Oldfield on oriented bilay-
ers of 1 : 1 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine
(DMPC)–desipramine.1 The appearance of signal intensity
at approximately half of the value of oriented in bilayers
containing 40 mol% (from 3 to C3 kHz) and 50 mol% (from
2.5 to C2.5 kHz desipramine [see Fig. 7(D) and (E), respec-
tively]) indicates the presence of small amounts of unoriented
bilayers. It is also noticeable that at these desipramine con-
centrations (40 and 50 mol%) the 14N lines are broader, in
agreement with the observed broadening of the 31P spec-
tra of 4 : 1 POPC–POPG bilayers with 50 mol% desipramine
incorporated (spectra not shown).
To distinguish a decrease in the 14N order parameter
due to an increase in disorder from a change in the POPC
headgroup conformation, the 31P chemical shift spectra of
oriented 4 : 1 POPC–POPG bilayers with bilayer normal
parallel to B0 were recorded in the presence of desipramine
concentrations at which desipramine was completely soluble
(below 30 mol%, Fig. 8). As the concentration of desipramine
is increased from 0 to 25 mol%, the chemical shift and width
of the peak at lower field, corresponding to the parallel edge
of POPC-enriched domain, remain relatively unchanged. We
conclude that the conformation of the POPC headgroup in the
phosphate region in the presence of miscible concentrations
of desipramine remains approximately the same and that the
observed decrease in the 14N quadrupole splitting of POPC
in the presence of desipramine can be assigned primarily to a
disordering effect. Interestingly, the chemical shift value and
its intensity of the peak at higher field in Fig. 8 vary more






31P Chemical Shift (ppm)
Figure 8. 31P chemical shift spectra of mechanically oriented
4 : 1 POPC–POPG at various molar concentrations of
desipramine: (A) 3; (B) 10; (C) 20; (D) 25 mol%. Dashed lines
are to guide the eye.
ratio of the intensities of the peaks never approaches 4 : 1,
the POPC : POPG stoichiometric ratio used in the sample,
indicating that the chemical shift and intensity of the peak at
higher field are a measure of the ternary interaction among
drug, POPC and POPG. In analogy with the observed effect of
increasing the concentration of POPG in POPC–POPG MLV
samples (Fig. 3), we propose that the absolute difference in
chemical shift values of the two peaks is indicative of the
miscibility of POPG in POPC bilayers and therefore of each
lipid domain composition. The apparent lack of a trend in
this absolute difference of chemical shifts with increasing
desipramine concentration is interpreted as a signal that the
composition of the two lipid domains is constantly changing
without reaching a steady state in the time of the experiment.
This issue will be addressed in further detail in the Discussion
section. A summary of the results obtained for MLV samples
is shown in Table 1.
DISCUSSION
It has been demonstrated previously that the TCA class
of compounds interacts with the lipid bilayer.1 – 4 The 31P
chemical shift spectra of binary lipid systems (charged drug
with POPC or POPG) in the present study clearly support
this conclusion by demonstrating that both imipramine and
desipramine interact with POPC in addition to POPG as
reflected by the changes in the CSA span. However, this
information does not address the question of how the
interaction of different TCAs with the lipid membrane may
contribute to the onset of distinguishing physiologically
observed direct and secondary effects by altering the
membrane lipid dynamics or conformation. This is precisely
the goal of this study. To date, the study of lipid–TCA
interactions had been reduced to observations on binary
systems TCA C PC with a single probe (either 14N or 31P).1,2
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To address the question posed, we made a comparison of the
effect of TCAs on ternary systems (TCA C two lipids) with
two different probes. This approach allowed us to determine
that the two TCAs, imipramine and desipramine, alter the
membrane structure and dynamics in distinct ways that may
be correlated with the observed differences in TCA-related
secondary effects. Specifically, it is shown that the effect of
the TCA on the lipid bilayer is highly dependent on the
TCA’s effective charge and also steric constraints.
Iminodibenzyl, a structural homologue of imipramine
and desipramine, retains the tricyclic structure of all
TCA compounds, but it is missing a charged acyl chain.
Incorporation of this compound into 4 : 1 POPC–POPG
system did not change the 14N order parameter of the
choline group of POPC [Fig. 6(D)]. In addition, the 31P
CSA span calculated from the powder spectrum of 4 : 1
POPC–POPG with 25 mol% iminodibenzyl incorporated
[Fig. 5(C)] was shown to be equal, within experimental error,
to that observed for the same lipid composition without the
drug. In support of an unchanged lipid bilayer conformation
and dynamics upon addition of iminodibenzyl, the 31P
spectra of oriented 4 : 1 POPC–POPG bilayers with and
without iminodibenzyl showed little change in the chemical
shift value of both peaks. Iminodibenzyl is thus shown
to act as an inert spacer between lipid molecules. This
observation is consistent with the absence of a reported
role of iminodibenzyl in induction of lipidosis.
In contrast to iminodibenzyl, both desipramine and
imipramine have charged acyl chains and induce lipidosis
in vivo (more acute for desipramine than imipramine).7 – 11 In
a previous study using 13C and 2H NMR,44 desipramine
and imipramine were shown to partition into the lipid
bilayer inducing the largest disordering effect on the lower
acyl chain carbons (6–14 in DMPC), which indicates that
both drugs penetrate the bilayer only down to the sixth
carbon on the lipid acyl chain. This disordering effect was
measured to be larger for desipramine than imipramine.
It has also been proposed that locating desipramine or
imipramine at the depth of carbon-6 would position the
charged amine at a short distance from either the lipid O2232
or O13 (Fig. 2) and a hydrogen bond forms between the
charged drug acyl chain and these lipid oxygens,45,46 also in
agreement with 13C and 1H NMR results from studies on
detergent micelles and liposomes that position the charged
acyl chain of TCAs at the air–water interface.47,48 Therefore,
it is not surprising that both imipramine and desipramine
interact with the lipid headgroups and that the extent of the
drug-induced bilayer disordering effect is correlated with
the effective charge of the drug. The results presented in
this study on the effect of the incorporation of these two
compounds into 4 : 1 POPC–POPG bilayers support both
of these conclusions. More importantly, our results show
that both imipramine and desipramine alter the bilayer
conformation and dynamics in distinct ways.
Incorporation of desipramine into 4 : 1 POPC–POPG
mixtures is observed to have a large disordering effect on the
choline headgroup of POPC while leaving the conformation
of the POPC and POPG headgroup at the phosphate site
unchanged. In support of this conclusion, the 14N quadrupole
splitting of the POPC choline headgroup in POPC–POPG
mixtures decreases from 11.5 š 0.2 to 7.5 š 0.2 kHz on
addition of 25 mol% desipramine while leaving the lipid
symmetry axis parallel to the bilayer normal. The decrease
in the quadrupole splitting was observed to be almost
linearly dependent on the desipramine concentration. The
decrease in the quadrupole splitting and order parameter
of the 14N nucleus could not be assigned to a change in
headgroup conformation since (1) the calculated 31P CSA
spans of POPC–POPG mixtures without drug and with 25
and 50 mol% desipramine incorporated are equal within
experimental error and (2) the 31P chemical shifts of the
peaks at higher field in oriented 4 : 1 POPC–POPG bilayers
with desipramine concentrations ranging from 0 to 25 mol%
are equal within experimental error. Importantly, it was the
use of 14N as a probe of the TCA–lipid interaction that
allowed the determination of a strong effect of desipramine
on the bilayer architecture as the 31P spectra show only small
changes.
In comparison with desipramine, incorporation of
imipramine into 4 : 1 POPC–POPG mixtures is observed to
decrease the 14N quadrupole splitting (or the order param-
eter) of the POPC choline headgroup to a smaller extent
than desipramine while concurrently increasing the 31P CSA
span. Because both the 31P CSA span and the 14N order
parameter change, it is not possible to assign the decrease in
the 14N order parameter solely to an increase in the choline
headgroup disorder. A change in conformation of the lipid
headgroup could also result in a decrease of the POPC choline
quadrupole splitting. The increase in CSA span upon inclu-
sion of imipramine occurs concurrently with homogenous
line broadening, which is indicative of a change in headgroup
dynamics as seen at the phosphate site. In conclusion and in
comparison with desipramine, the inclusion of imipramine
in 4 : 1 POPC–POPG bilayers is observed to have an effect on
the conformation and/or dynamics at both the choline and
phosphate sites whereas desipramine is observed to increase
mostly the disorder of the choline headgroup while leaving
the conformation of the phosphate site largely unchanged.
The conclusion presented above was made based on the
effect of each drug on POPC bilayers containing a smaller
concentration of POPG. An assessment of the effect of each
drug on the POPG headgroup is difficult to make since
in mixed POPC–POPG the 31P resonances of POPG have
a contribution from POPC. The best evidence that this
overlap exists is that none of the 31P spectra of oriented
4 : 1 POPC–POPG showed the ratio of the intensities of the
two peaks approaching to 4 : 1 ratio used in the mixture.
Instead, the ratios were always in the range of 2.2 : 1–2.8 : 1.
Since the 31P CSA span of POPG remains unchanged within
experimental error with and without desipramine, to a first
approximation, the effect of POPC and desipramine on the
POPG headgroup is the same. In comparison, imipramine
clearly changes the POPG headgroup conformation and
dynamics as shown by a significant increase in the 31P
CSA span of POPG with and without imipramine. In
4 : 1 POPC–POPG bilayers with drug, the chemical shift
difference between the two peaks is taken as a measure
of the miscibility of POPC in POPG. An increase in the
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difference relative to the spectra of drug-free bilayers as seen,
for example, in bilayers with 25 mol% imipramine suggests
that imipramine makes POPC less miscible in POPG most
likely because the positively charged imipramine competes
with POPC for an interaction with POPG. Noticeably, the
miscibility of POPC in POPG is also, but to a much lesser
extent, dependent on the desipramine concentration.
Guided by the results from previous studies that showed
that both desipramine and imipramine insert into the lipid
bilayer positioning the charged acyl chain at the depth of
O13 or O2232 (Fig. 2) and possibly making a hydrogen bond
with these sites, the new results presented here allow us
to formulate a crude structural model for the interaction of
TCA with the lipid headgroup. Computer simulation studies
of pure lipid bilayers of phosphatidylcholines indicated
that the primary interactions between lipids headgroups
are hydrogen bonds and charge associations between the
choline nitrogen and O13 and O2232.19 Our data suggest that
the acyl chains in both imipramine and desipramine whose
charged amine resembles the choline headgroup of POPC
interact with the phosphate site of both POPC and POPG.
In both cases, we propose that the interaction of the charged
amine of imipramine and desipramine with the phosphate
sites of POPG and POPC makes the phosphate sites of these
lipids less available for lipid ‘cross-linking’. Visually this can
be seen as a ‘release’ of the choline headgroup or P—N
vector (Fig. 2), which allows it to have a greater amplitude of
motion reported by the 14N spectra as an increase in disorder
(decrease of order parameter). Electrostatically, the repulsion
between the charged drug amine and the choline headgroup
can also contribute to this effect. The more unshielded
charge of desipramine is able to substitute, to a very good
approximation, the interaction of POPC choline with POPG
and/or POPC phosphate. This conclusion is supported by
equal 31P CSA spans within experimental errors for spectra
of POPG in the presence of POPC or desipramine and by
the relatively unchanged chemical shift of POPC in oriented
bilayers of 4 : 1 POPC–POPG with and without desipramine.
Imipramine is different from desipramine in that its more
sterically shielded charge does not substitute well for the
interaction of the choline POPC with the phosphate groups
of either POPC or POPG. The dramatic increase in the 31P CSA
span of 4 : 1 POPC–POPG mixture and in the chemical shifts
of both peaks in oriented lipid bilayers upon the inclusion
of imipramine supports this conclusion. In summary, this
model confirms that there is a correlation between the
effective charge of TCA as well as steric constraints and
observed changes in bilayer architecture. Furthermore, this
model argues for a need to probe both regions (phosphate
and choline) of the lipid headgroup to ascertain the effect of
amphiphiles on bilayer architecture.
It should be mentioned that the drug concentrations
used in this study are orders of magnitude above what
is seen at the macroscopic level in vivo.7 – 11 However, it is
possible that lower microscopic drug concentrations may
induce significant changes in bilayer architecture such
as those outlined in this study. Furthermore, it is also
conceivable that if secondary effects (e.g. lipidosis) resulting
from the ingestion of TCA-like compounds are induced
by the inability of the phospholipase to interact with the
membrane, then the membrane changes necessary to abolish
those interactions need only be much smaller than those
observed spectroscopically in this study. For these reasons,
this study provides a step forward towards understanding
the interactions of TCAs with lipid bilayers that may be
related to the ability of the compounds to induce lipidosis.
Finally, we conclude that, unless the propensity of TCAs
to induce lipidosis is shown in subsequent studies to be
well correlated with the ability of these compounds to
increase the disorder of the lipid bilayers closest to the
cytoplasm (e.g. choline sites in phosphatidylcholines) while
leaving the conformation of the phosphate region of the lipid
headgroup largely unchanged, the effects of TCA addition
to lipid bilayers does not explain lipidosis as we observe that
imipramine imparts more dramatic changes in the overall
bilayer architecture than desipramine.
CONCLUSIONS
The combined application of 14N and 31P solid-state NMR
experiments to study the interaction of antidepressants
with lipids was shown to provide a clearer picture of
the drug-induced changes in the lipid bilayer.49 In this
model, inclusion of charged TCA was shown to change lipid
conformation and/or dynamics. Specifically, addition of the
charged TCA desipramine to 4 : 1 POPC–POPG mixtures
was shown to increase the choline site disorder, leaving the
conformation of the phosphate region of POPC and of the
POPG headgroups largely unchanged. The incorporation
of imipramine into lipid bilayers was shown to modulate
both lipid conformation and dynamics. The changes in
bilayer architecture imposed by the addition of desipramine
and imipramine could modify the interactions between the
bilayer and other membrane-associated proteins, possibly
contributing to such TCA side-effects as lipidosis. However,
it is noted that imipramine, which has a lower propensity
to induce lipidosis in vivo, has a larger effect on overall
bilayer architecture than desipramine, thereby arguing
that TCA-mediated changes in lipid bilayer conformation
and dynamics and the ability to induce lipidosis are not
straightforward. In general, this study provides a generalized
structural picture for the ability of amphiphiles with charged
‘headgroups’ capable of inserting into the lipid bilayer to
change the properties of the membrane. Further studies
on how the incorporation of TCA mediates the binding
constants and activities of proteins that require interactions
with anionic lipids (e.g. DnaA, antimicrobial peptides and
phospholipases) will be particularly helpful in confirming
the results outlined in this paper.
The present study has also demonstrated that 14N NMR
has the potential of being a very useful probe to study
model membranes. Its natural abundance (99.63%) in a
wide variety of phospholipids, particularly among the
nitrogenous-base containing glycerophosphatides such as
PC, makes it particularly attractive. Since the biological
function of peptides, proteins or drugs in the cell membrane
is highly dependent on the lipid environment, it will be
useful to study the peptide or protein interactions with
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the lipid bilayers under various experimental conditions.
Most importantly, the use of 14N NMR for probing lipid
bilayers provides previously unavailable information. As an
example, this TCA–lipid interaction study indicates that 14N
solid-state NMR is capable of differentiating between the
effects on bilayer architecture of compounds whose charge
is only slightly different, as is the case for desipramine and
imipramine. We trust that the advent of higher magnetic
fields, the development of new solid-state NMR techniques
and significant improvements in preparing membrane-
mimicking model samples will lead to more successful
studies of 14N NMR spectroscopy applied to non-isotropic
biological samples.
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